Showing results (111-120 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|February 6, 1999
A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescentsJ Renaud, D Axelson, B Birmaher
Drug Safety|February 6, 1999
Treatment of cardiac arrhythmias during pregnancy: safety considerationsJ A Joglar, R L Page
Drug Safety|January 8, 1999
Risk of adverse events with the use of augmentation therapy for the treatment of resistant depressionI Schweitzer, V Tuckwell
Drug Safety|November 24, 1998
Post-marketing studies: the work of the Drug Safety Research UnitF J Mackay
Drug Safety|November 24, 1998
Drug interactions of lipid-altering drugsH E Bays, C A Dujovne
Drug Safety|February 4, 2006
Advances in understanding drug-induced neuropathiesAmanda C Peltier, James W Russell
Drug Safety|February 4, 2006
Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?Neil H Shear
Drug Safety|February 4, 2006
The prevalence of potential drug-drug interactions in patients with heart failure at hospital dischargeBernhard Straubhaar, Stephan Krähenbühl, Raymond G Schlienger
Drug Safety|February 4, 2006
Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in EnglandBeate Aurich-Barrera, Lynda Wilton, Scott Harris, et al.
Drug Safety|February 4, 2006
HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systemsAlfonso Carvajal, Diego Macias, María Sáinz, et al.
Pageof 308